Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease

Jeffrey S. Hyams, Meena Thayu, Marla C. Dubinsky et al.|Gastroenterology|2017

Cited by 217